Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.9405
-0.1295 (-12.10%)
At close: May 26, 2026, 4:00 PM EDT
0.9547
+0.0142 (1.51%)
After-hours: May 26, 2026, 5:47 PM EDT
RANI Market Cap
RANI has a market cap or net worth of $93.87 million as of May 26, 2026. Its market cap has increased by 260.35% in one year.
Market Cap
93.87M
Enterprise Value
56.90M
1-Year Change
260.35%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since the IPO on July 30, 2021, RANI's market cap has decreased from $206.13M to $93.87M, a decrease of -54.46%. That is a compound annual growth rate of -15.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 106.80M | -18.90% |
| Dec 31, 2025 | 131.69M | 188.57% |
| Dec 31, 2024 | 45.64M | -46.89% |
| Dec 29, 2023 | 85.92M | -41.09% |
| Dec 30, 2022 | 145.85M | -54.75% |
| Dec 31, 2021 | 322.29M | 56.36% |
| Jul 30, 2021 | 206.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aldeyra Therapeutics | 101.34M |
| Rein Therapeutics | 99.09M |
| Biomea Fusion | 99.05M |
| Pelthos Therapeutics | 96.80M |
| ProMIS Neurosciences | 96.04M |
| Oncolytics Biotech | 95.83M |
| ImmuCell | 95.62M |
| PolyPid | 94.27M |